Sublingual Dexmedetomidine for Treating Opioid Withdrawal

Clinical trial NCT05712707 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05712707
Sponsor: New York State Psychiatric Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Opioid Use Disorder Opioid Withdrawal

Start date: 2023-02-28
Primary completion: 2025-06-30
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.